EW
Edwards Lifesciences Corp
85.80$
-0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.4% | 43.1% | 42.8% | 44.7% | 51.9% | 48.1% | 47.7% | 48.8% | 47.9% | 49.2% | 46.8% | 49.2% | |
| 15.0% | 12.1% | 12.6% | 16.3% | 28.3% | 23.3% | 24.1% | 24.3% | 20.2% | 21.5% | 18.4% | 21.0% | |
| 19.9% | 17.4% | 17.4% | 19.7% | 34.3% | 30.5% | 29.9% | 30.1% | 28.9% | 30.9% | 27.6% | 30.7% | |
| 8.6% | 8.8% | 9.0% | 8.3% | 6.3% | 5.6% | 5.8% | 6.7% | 6.7% | 6.7% | 7.3% | 6.9% | |
| 11.0% | 9.6% | 12.4% | 10.1% | 8.5% | 8.3% | 8.6% | 8.5% | 8.6% | 8.2% | 8.4% | 8.2% | |
| 18.9% | – | – | – | 13.7% | 13.7% | 13.8% | 13.5% | 13.9% | 14.0% | – | – | |
| 13.8% | 12.2% | 12.9% | 11.4% | 12.4% | 13.6% | 13.7% | 13.2% | 13.3% | 12.9% | 13.7% | 14.1% | |
| 4.6% | 4.3% | 4.6% | 4.1% | 7.4% | 9.0% | 9.0% | 8.7% | 8.5% | 8.2% | 9.2% | 10.0% | |
| 28.2% | 28.2% | 26.2% | 25.7% | 25.9% | 22.9% | 21.7% | 21.4% | 23.1% | 24.5% | 22.5% | 22.7% | |
| 13.2% | 12.8% | 11.4% | 12.1% | 15.0% | 11.5% | 10.7% | 10.4% | 12.0% | 13.2% | 10.6% | 10.9% | |
| 0.3% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | |
| 2.0% | 2.0% | 2.2% | 1.8% | 1.3% | 1.5% | 1.3% | 1.2% | 1.2% | 1.7% | 1.4% | 1.5% | |
| 6.4% | 6.4% | 6.1% | 5.9% | 4.6% | 4.6% | 4.6% | 4.4% | 4.5% | 4.4% | 4.5% | 4.3% | |
| 71.0% | 71.0% | 73.1% | 73.6% | 73.6% | 76.6% | 77.8% | 78.2% | 76.9% | 75.5% | 77.5% | 76.6% | |
| 92.0% | 96.0% | 96.0% | 96.2% | 98.5% | 100.9% | 103.9% | 102.7% | 106.6% | 104.0% | 109.8% | 107.2% | |
| 6.5% | 6.5% | 6.2% | 6.0% | 4.6% | 4.5% | 4.5% | 4.4% | 4.4% | 4.2% | 4.4% | 4.2% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.